Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of GLP-1 on microvascular function in patients with type 2 diabetes
2012-005013-38Phase 4Completed
- Start
- Feb 2013
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in type 2 diabetes mellitus (T2DM), microvascular angina (MVA), Coronary Small Vessel Disease (CMD). Started Feb 2013; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)microvascular angina (MVA)Coronary Small Vessel Disease (CMD)
Beyond the preview
Go deeper on 2012-005013-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005013-38.